Home › Biliary Atresia › NCT03273049

Mapping Disease Pathways for Biliary Atresia

Coordinating Center- Mapping Disease Pathways for Biliary Atresia

Who can join

All ages · All sexes

Inclusion Criteria:

* living individuals who were diagnosed with Biliary Atresia and received or are about to receive a liver transplant from multiple participating centers (Children's Hospital of Pittsburgh, Kings College Hospital, Children's Hospital of Birmingham, and Hospital Sírio-Libanês).

Exclusion Criteria:

* No child participant in the care of the state will be enrolled, nor will patients in the care of temporary or informal guardians be enrolled

About the study

This project will primarily evaluate the developmental/genetic basis of biliary atresia, the most common cause of liver failure at birth, and which accounts of half of all liver transplants performed worldwide in children.

Sponsor: University of Pittsburgh · Participants: 1,100 · Started: Jul 21, 2016

Contact the study team

• Morgan L Paul, BSN · Phone: 4126928472
• Daniel Pieratt, MPA · Phone: 4126926692

Official record on ClinicalTrials.gov — NCT03273049

Locations in the U.S.

Conditions

• Biliary Atresia

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.